Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
Jerry Siegel, PHARMD, FASHP
For the past several years, the availability of Ig products has been very good, so product shortages have not played a major role in product choice. This gives clinicians the opportunity to match the best product to the patient based on the patient's clinical condition and comorbidities.
